Advertisement

Drugs & Therapy Perspectives

, Volume 5, Issue 9, pp 12–14 | Cite as

Pharmacokinetic drug interactions with antineoplastic agents

Drug Reactions and Interactions

Keywords

Methotrexate Allopurinol Antineoplastic Agent Pharmaceutical Care Antineoplastic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Loadman PM, Bibby MC. Pharmacokinetic drug interactions with anti-cancer drugs. Clin Pharmacokinet 1994; 26: 486–500PubMedCrossRefGoogle Scholar
  2. 2.
    Liliemark J, Peterson C. Pharmacokinetic optimisation of anticancer therapy. Clin Pharmacokinet 1991; 21: 213–31PubMedCrossRefGoogle Scholar
  3. 3.
    Cytotoxic drug interactions. In: Stockley IH. Drug interactions: a source book of adverse interactions, their mechanisms, clinical importance and management. 3rd ed. Oxford: Blackwell Scientific Publications, 1994; 279, 462–97Google Scholar
  4. 4.
    van Meerten E, Verweij J, Schellens JHM. Antineoplastic agents: drug interactions of clinical significance. Drug Saf 1995; 12(3): 168–82PubMedCrossRefGoogle Scholar
  5. 5.
    Mayall B, Poggi G, Parkin JD. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal. Med J Aust 1991; 155: 480–4PubMedGoogle Scholar
  6. 6.
    Johnson AG, Seidemann P, Day RO. NSAID-related adverse drug interactions with clinical relevance. Int J Clin Pharmacol Ther 1994; 10: 509–32Google Scholar
  7. 7.
    Harvey VJ, Slevin ML. Dilloway MR, et al. The influence of cimetidine on the pharmacokinetics of 5-fluorouracil. Br J Clin Pharmac 1984; 18: 421–30CrossRefGoogle Scholar
  8. 8.
    Saaki Y, et al. Simultaneous administration of CPT-11 and fluorouracil: alteration of the pharmacokinetics of CPT-11 and SN-38 in patients with advanced colorectal cancer. J Natl Cancer Inst 1994; 86: 1096–98CrossRefGoogle Scholar
  9. 9.
    Lum BL, Kaubisch S, Yahanda AM, et al. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 1992; 10: 1635–42PubMedGoogle Scholar
  10. 10.
    Rabinowits M, Souhami L, Gil RA, et al. Increased pulmonary toxicity with bleomycin and cisplatin chemotherapy combinations. Am J Clin Oncol 1990; 13: 132–8PubMedCrossRefGoogle Scholar
  11. 11.
    Goren MP, Wright PK, Pratt CB, et al. Potentiation of ifosfamide neurotoxicity, hematoxicity, and tubular nephrotoxicity by prior cis-diamminedichlorplatinum (II) therapy. Cancer Res 1987; 47: 1457–60PubMedGoogle Scholar

Copyright information

© Adis International Limited 1995

Personalised recommendations